Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Two helium units at Amursky GPP reached their design capacity

1/25/24 GAZP

SPX Exchange shareholders agreed to liquidate the Board of Directors

1/25/24 SPBE

Amur GPP will be connected to Sakhalin in 2029

1/25/24 GAZP

Henderson is ready to pay a dividend

1/25/24 HNFG

Henderson has summarized its performance in 2023

1/25/24 HNFG

Unipro increased electricity generation by 4.8% in 2023

1/25/24 UPRO

TGC-1 summarized its performance in 2023

1/25/24 TGKA

MD Medical opened a family-format multidisciplinary clinic

1/25/24 MDMG

MMK in 2023 increased sales of steel products by 10%

1/25/24 MAGN

Bank Saint-Petersburg summarized preliminary results for 2023

1/25/24 BSPB